Literature DB >> 9692901

Mapping of the binding of platelet-derived growth factor to distinct domains of the basement membrane proteins BM-40 and perlecan and distinction from the BM-40 collagen-binding epitope.

W Göhring1, T Sasaki, C H Heldin, R Timpl.   

Abstract

A surface plasmon resonance assay was used to analyze the binding of platelet-derived growth factor (PDGF)-AA and PDGF-BB to various proteins of the extracellular matrix. This identified several collagen types; laminin-1, nidogen, perlecan and BM-40 as potential ligands for PDGF with Kd values in the range 2-3200 nM. Perlecan and BM-40 were used to examine the domain specificity and other parameters of the interactions. Recombinant human and mouse BM-40 were shown to bind both PDGFs in a similar manner with a Kd of about 5-10 nM. Studies with deletion mutants of human BM-40 demonstrated binding to its C-terminal extracellular calcium-binding (EC) module, yet the interaction did not require calcium. This distinguishes this from the binding of the EC module to various collagen types, which is strictly calcium dependent. Furthermore, deletion of helix alphaC or two point mutations in helix alphaA of the EC module either enhanced or abolished binding to collagen IV. Since these mutations had no effects on binding to PDGF, it demonstrated the presence of two different binding epitopes. Binding of PDGF-BB to the perlecan core protein could be mapped to its domain III-2 (Kd = 8 nM) with lower affinities shown for domains I, IV-1 and V (Kd = 34-64 nM). Other perlecan domains (II, III-1, III-3, IV-2) were inactive. PDGF-AA was also shown to bind domain III-2 but not III-1. Neither nidogen, BM-40 or perlecan domain III-2 interfered with the binding of PDGF to its alpha and beta receptors, however, suggesting that these interactions may be mainly used for storage of PDGF in the extracellular matrix.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9692901     DOI: 10.1046/j.1432-1327.1998.2550060.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  42 in total

1.  Binding of the G domains of laminin alpha1 and alpha2 chains and perlecan to heparin, sulfatides, alpha-dystroglycan and several extracellular matrix proteins.

Authors:  J F Talts; Z Andac; W Göhring; A Brancaccio; R Timpl
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

2.  Complete sequence, recombinant analysis and binding to laminins and sulphated ligands of the N-terminal domains of laminin alpha3B and alpha5 chains.

Authors:  Jörg H O Garbe; Walter Göhring; Karlheinz Mann; Rupert Timpl; Takako Sasaki
Journal:  Biochem J       Date:  2002-02-15       Impact factor: 3.857

Review 3.  Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena.

Authors:  R V Iozzo; J D San Antonio
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

4.  Osteonectin/SPARC secreted by RPE and localized to the outer plexiform layer of the monkey retina.

Authors:  I R Rodríguez; E F Moreira; D Bok; M Kantorow
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-08       Impact factor: 4.799

5.  Characterization of SMOC-2, a modular extracellular calcium-binding protein.

Authors:  Christian Vannahme; Silke Gösling; Mats Paulsson; Patrik Maurer; Ursula Hartmann
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

Review 6.  Corneal wound healing.

Authors:  Steven E Wilson
Journal:  Exp Eye Res       Date:  2020-06-15       Impact factor: 3.467

Review 7.  Basement membranes: cell scaffoldings and signaling platforms.

Authors:  Peter D Yurchenco
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-02-01       Impact factor: 10.005

Review 8.  Extracellular matrix, inflammation, and the angiogenic response.

Authors:  Alicia G Arroyo; M Luisa Iruela-Arispe
Journal:  Cardiovasc Res       Date:  2010-02-12       Impact factor: 10.787

Review 9.  Role of perlecan in skeletal development and diseases.

Authors:  John Hassell; Yoshihiko Yamada; Eri Arikawa-Hirasawa
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

10.  Perlecan: an important component of the cartilage pericellular matrix.

Authors:  R Gomes; C Kirn-Safran; M C Farach-Carson; D D Carson
Journal:  J Musculoskelet Neuronal Interact       Date:  2002-12       Impact factor: 2.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.